ARDELYX, INC. — Director's Dealing 2015

Sep 2, 2015

SEC Form 4/A — Form 4/A

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2015-07-30

Reporting Person: Rosenbaum David P. (SVP, Drug Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-30	Common Stock	S	2011	$19.2716	Disposed	25880	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77592	Indirect

Footnotes

F1: This amendment is being filed to correct the account under which the reporting person sold and to report the original source of the shares sold.

F2: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 18, 2015.

F3: The 2,011 shares reported as sold herein were originally acquired under the Issuer's Employee Stock Purchase Plan on February 27, 2015.

F4: This transaction was executed in multiple trades in prices ranging from $19.19 to $19.566, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.